Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer.

BACKGROUND AND PURPOSE In 3D treatment planning of low dose rate brachytherapy of cervical carcinoma the dose in bladder and rectum can be estimated from dose-volume histograms (DVHs). In this study, the influence of inter-observer variation in delineation of bladder and rectum on DVHs and dose at specific bladder and rectum points was investigated. MATERIALS AND METHODS Three observers delineated bladder and rectum on axial CT images of ten patients. The highest minimum dose in bladder and rectum was determined for, respectively, 2 cm(3) (D(2)) and 5 cm(3) (D(5)), as well as the dose at specific points placed on the bladder and rectum wall. RESULTS The inter-observer variation in D(2) was 10% (1 average relative SD) in bladder and 11% (1 SD) in rectum. In D(5) the variation was 8% (1 SD) in bladder and 11% in rectum. The variation in the bladder point was 13% (1 SD) and in the rectum point 11% (1 SD). Differences in delineation among the observers were caused by unclear organ boundaries on the CT images. CONCLUSIONS Taking the inter-observer variation caused by delineation differences into account, dose in bladder and rectum can be determined within an accuracy of about 10% (1 SD).

[1]  J C Ehrhardt,et al.  Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. , 1996, International journal of radiation oncology, biology, physics.

[2]  L. Coia,et al.  Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. , 1991, International journal of radiation oncology, biology, physics.

[3]  S L Schoeppel,et al.  Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. , 1994, International journal of radiation oncology, biology, physics.

[4]  A. Dixon,et al.  A CT based dosimetry system for intracavitary therapy in carcinoma of the cervix. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  I. Barillot,et al.  Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  C. Haie-meder,et al.  Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. , 1994, International journal of radiation oncology, biology, physics.

[7]  J. Lebesque,et al.  An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder. , 1997, International journal of radiation oncology, biology, physics.

[8]  M van Herk,et al.  Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[9]  D. McShan,et al.  A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning. , 1989, International journal of radiation oncology, biology, physics.

[10]  H. Meertens,et al.  The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S L Schoeppel,et al.  Magnetic resonance imaging during intracavitary gynecologic brachytherapy. , 1992, International journal of radiation oncology, biology, physics.

[12]  C. Moore,et al.  Bladder base dosage in patients undergoing intracavitary therapy. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  A. Gerbaulet,et al.  Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix--the Villejuif experience, 1975-1984. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Wharton,et al.  Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. , 1995, International journal of radiation oncology, biology, physics.

[15]  C C Ling,et al.  CT-assisted assessment of bladder and rectum dose in gynecological implants. , 1987, International journal of radiation oncology, biology, physics.

[16]  T. Nakano,et al.  Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer. , 1996, International journal of radiation oncology, biology, physics.

[17]  G. Stuecklschweiger,et al.  Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  J. Purdy,et al.  Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications , 1984, Cancer.